Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07596992
NA

Effects of Royal Jelly and Propolis on Metabolomic Signatures, Inflammation, and Cardiovascular Risk in Patients With Coronary Artery Disease.

Sponsor: Universidade Federal Fluminense

View on ClinicalTrials.gov

Summary

The aim of this project is to evaluate the effect of bioactive compound sources, propolis and royal jelly, on metabolomics, inflammation, and cardiovascular risk markers in participants with coronary artery disease. A longitudinal double-blind randomized clinical trial will be carried out, involving CAD participants for two months.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

50

Start Date

2026-05-18

Completion Date

2028-12

Last Updated

2026-05-19

Healthy Volunteers

No

Interventions

DIETARY_SUPPLEMENT

Propolis + Royal Jelly

They will receive 4 capsules per day, providing 300 mg of royal jelly per day and 500 mg of propolis per day.

DIETARY_SUPPLEMENT

Placebo

They will receive 4 capsules per day, providing daily delivery of the active formulation vehicle (microcrystalline cellulose and magnesium stearate in colored gelatin capsules capable of masking the appearance of the internal contents).

Locations (1)

Denise mafra

Niterói, Rio de Janeiro, Brazil